UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A7K7QI95 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A7K7QID3 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7K7QEI7 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7K7R017 | ATS1 metalloproteinase (Fragment) |
|
2 | 0 |
|
A0A7K7QT11 | N-acetylgalactosamine-6-sulfatase (Fragment) |
|
1 | 0 |
|
A0A7K7QI07 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7K7QEZ0 | Hyaluronidase (Fragment) |
|
1 | 0 |
|
A0A7K7R2L8 | Rhodopsin (Fragment) |
|
2 | 0 |
|
A0A7K7R9C1 | KCNKH protein (Fragment) |
|
1 | 0 |
|
A0A7K7QNT9 | Protein adenylyltransferase FICD (Fragment) |
|
1 | 0 |
|
A0A7K7QR29 | NOGG protein (Fragment) |
|
1 | 0 |
|
A0A7K7QU71 | Fibroblast growth factor receptor 2 (Fragment) |
|
8 | 0 |
|
A0A7K7R768 | GDNF family receptor alpha-2 (Fragment) |
|
2 | 0 |
|
A0A7K7R2C8 | Fibroblast growth factor receptor 1 (Fragment) |
|
8 | 0 |
|
A0A7K7R7D3 | Rhodopsin (Fragment) |
|
2 | 0 |
|
A0A7K7R025 | ATS5 metalloproteinase (Fragment) |
|
1 | 0 |
|
A0A7K7QZW5 | Voltage-dependent L-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7K7R4R2 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase (Fragment) |
|
1 | 0 |
|
A0A7K7QE56 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A7K7QNN9 | BACE2 secretase (Fragment) |
|
1 | 0 |
|
A0A7K7R5H5 | Angiotensin-converting enzyme (Fragment) |
|
6 | 0 |
|
A0A7K7QQ51 | P2X purinoceptor (Fragment) |
|
1 | 0 |
|
A0A7K7QFA7 | Pannexin (Fragment) |
|
1 | 0 |
|
A0A7K7QR01 | Voltage-dependent T-type calcium channel subunit alpha (Fragment) |
|
1 | 0 |
|
A0A7K7QHV4 | Potassium channel subfamily K member 1 (Fragment) |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024